138 related articles for article (PubMed ID: 26337302)
41. Clinical, laboratory biomarkers and imaging findings of pancreatic adenocarcinoma in Iran.
Hadizadeh M; Padashi M; Mohammad Alizadeh AH; Zali MR
Asian Pac J Cancer Prev; 2014; 15(10):4349-52. PubMed ID: 24935395
[TBL] [Abstract][Full Text] [Related]
42. Clinicopathological patterns of colorectal cancer in Tunisia.
Missaouia N; Jaidaine L; Ben Abdelkader A; Beizig N; Anjorin A; Yaacoubi MT; Hmissa S
Asian Pac J Cancer Prev; 2010; 11(6):1719-22. PubMed ID: 21338221
[TBL] [Abstract][Full Text] [Related]
43. Cancer of corpus uteri in Tunisia: epidemiological and clinicopathological features.
Missaoui N; Jaidene L; Abdelkader AB; Abdelkrim SB; Beizig N; Yaacoub LB; Yaacoubi MT; Hmissa S
Asian Pac J Cancer Prev; 2011; 12(2):461-4. PubMed ID: 21545213
[TBL] [Abstract][Full Text] [Related]
44. [Cancers of the pancreas at the National Hospital and University Center of Cotonou: epidemiological, diagnostic, therapeutic and prognostic features].
Kpossou AR; Gbessi DG; Gnangnon FHR; Ba Boukari MM; Vignon RK; Sokpon CNDM; Sehonou J
Pan Afr Med J; 2021; 39():18. PubMed ID: 34394809
[TBL] [Abstract][Full Text] [Related]
45. Patient characteristics and treatment considerations in pancreatic cancer: a population based study in the Netherlands.
Zijlstra M; van der Geest LGM; van Laarhoven HWM; Lemmens VEPP; van de Poll-Franse LV; Raijmakers NJH
Acta Oncol; 2018 Sep; 57(9):1185-1191. PubMed ID: 29741436
[TBL] [Abstract][Full Text] [Related]
46. Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage.
Porta M; Fabregat X; Malats N; Guarner L; Carrato A; de Miguel A; Ruiz L; Jariod M; Costafreda S; Coll S; Alguacil J; Corominas JM; Solà R; Salas A; Real FX
Clin Transl Oncol; 2005 Jun; 7(5):189-97. PubMed ID: 15960930
[TBL] [Abstract][Full Text] [Related]
47. [Management of exocrin pancreatic tumor. About 129 cases].
Fall B; Cissé M; Ndoye JM; Konaté I
Dakar Med; 2008; 53(1):32-7. PubMed ID: 19102115
[TBL] [Abstract][Full Text] [Related]
48. Impact of ethnicity on outcome in pancreatic carcinoma.
Saif MW; Sviglin H; Carpenter M
JOP; 2005 May; 6(3):246-54. PubMed ID: 15883475
[TBL] [Abstract][Full Text] [Related]
49. Care pathway of patients with metastatic pancreatic cancer in daily practice in France: Results from the REPERE national survey.
Hammel P; Coriat R; Lledo G; de Bausset M; Selosse M; Obled S; Bonnetain F
Bull Cancer; 2017 Apr; 104(4):321-331. PubMed ID: 28087054
[TBL] [Abstract][Full Text] [Related]
50. Current treatment strategies for pancreatic cancer in the elderly.
Hanada K; Hino F; Amano H; Fukuda T; Kuroda Y
Drugs Aging; 2006; 23(5):403-10. PubMed ID: 16823993
[TBL] [Abstract][Full Text] [Related]
51. [Cancer from the exocrine pancreas].
Bjerregaard JK; Fristrup C; Pfeiffer P; Mortensen PM
Ugeskr Laeger; 2013 Nov; 175(48):2941-4. PubMed ID: 24629436
[TBL] [Abstract][Full Text] [Related]
52. [A Retrospective Study of 42 Lung Cancer Patients with Pancreatic Metastases].
Zhang Y; Chen M; Zhao J; Zhong W; Xu Y; Wang M
Zhongguo Fei Ai Za Zhi; 2019 Apr; 22(4):228-232. PubMed ID: 31014441
[TBL] [Abstract][Full Text] [Related]
53. [Fight against cancer of the exocrine pancreas: stagnation or progress? The point of view of the Fondation française de cancérologie digestive (FFCD)].
Bedenne L; Villing AL; Chauffert B
Cancer Radiother; 1997; 1(5):555-63. PubMed ID: 9587389
[TBL] [Abstract][Full Text] [Related]
54. Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients.
Fiorentini G; Sarti D; Casadei V; Milandri C; Dentico P; Mambrini A; Nani R; Fiorentini C; Guadagni S
Integr Cancer Ther; 2019; 18():1534735419878505. PubMed ID: 31561722
[No Abstract] [Full Text] [Related]
55. Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data.
Mendis S; Lipton L; To YH; Ananda S; Michael M; McLachlan SA; Thomson B; Loveday B; Knowles B; Fox A; Nikfarjam M; Usatoff V; Shapiro J; Clarke K; Pattison S; Chee CE; Zielinski R; Wong R; Gibbs P; Lee B
Br J Cancer; 2024 May; 130(9):1477-1484. PubMed ID: 38448752
[TBL] [Abstract][Full Text] [Related]
56. [Pancreatic cancer: Epidemiological, clinical, and management aspects in the department of hepatogastroenterology at the Lome Campus teaching hospital (Togo)].
Bouglouga O; Lawson-Ananissoh LM; Bagny A; Kaaga L; Redah D
Med Sante Trop; 2015; 25(3):323-6. PubMed ID: 26446745
[TBL] [Abstract][Full Text] [Related]
57. Diagnosing and managing pancreatic cancer.
Huggett MT; Pereira SP
Practitioner; 2011; 255(1742):21-5, 2-3. PubMed ID: 21932502
[TBL] [Abstract][Full Text] [Related]
58. Describing Patterns of Care in Pancreatic Cancer: A Population-Based Study.
Burmeister EA; OʼConnell DL; Beesley VL; Goldstein D; Gooden HM; Janda M; Jordan SJ; Merrett ND; Payne ME; Wyld D; Neale RE;
Pancreas; 2015 Nov; 44(8):1259-65. PubMed ID: 26262591
[TBL] [Abstract][Full Text] [Related]
59. [Epidemiological and clinical aspects of pancreatic cancer in Senegal].
Mbengue M; Ka MM; Dangou JM; Ka EH; Diouf MM; Sané A; Fall B; Touré CT; Moreira-Diop T
Dakar Med; 1998; 43(2):209-12. PubMed ID: 10797965
[TBL] [Abstract][Full Text] [Related]
60. Staging of cancer of the pancreas. Cancer of the Pancreas Task Force.
Cancer; 1981 Mar; 47(6 Suppl):1631-9. PubMed ID: 7272913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
